Emily Feng
Emily Feng is NPR's Beijing correspondent.
Feng joined NPR in February 2019. She roves around China, through its big cities and small villages, reporting on social trends as well as economic and political news coming out of Beijing. Feng contributes to NPR's newsmagazines, newscasts, podcasts, and digital platforms.
From 2017 through 2019, Feng served as a foreign correspondent for the Financial Times. Based in Beijing, she covered a broad range of topics, including human rights, technology, and the environment. While in this position, Feng made four trips to Xinjiang under difficult reporting circumstances. During these trips, Feng reported extensively on China's detention and surveillance campaign in the western region of Xinjiang, was the first foreign reporter to uncover that China was separating Uighur children from their parents and sending them to state-run orphanages, and uncovered that China was introducing forced labor in Xinjiang's detention camps.
Feng's reporting has also let her nerd out over semiconductors and drones, trek out to coal towns and steel mills, travel to environmental wastelands, and write about girl bands and art.
Prior to her work with the Financial Times, Feng freelanced in Beijing, covering arts, culture, and business for such outlets as The New York Times, Foreign Policy, and The Economist.
For her coverage of human rights abuses in Xinjiang, Feng was shortlisted for the Amnesty Media Awards in February 2019 and won a Human Rights Press merit award for breaking news coverage that May. Feng also earned two spots on the October 2018 British Journalism Awards shortlists: Best Foreign Coverage for her work covering Xinjiang, and Young Journalist of the Year for overall reporting excellence.
Feng graduated cum laude from Duke University with a dual B.A. degree from Duke's Sanford School in Asian and Middle Eastern studies and in public policy.
-
China banned fentanyl last year, but an NPR investigation reveals how Chinese vendors continue to market the chemicals used to make the drug on e-commerce and social media sites. -
Although the leading vaccine candidates are not yet officially approved, the drug companies are administering them to hundreds of thousands of people.
-
President Trump has been saying there will be a coronavirus vaccine "within weeks," and drugmakers are racing to produce one. In China, hundreds of thousands of people have already gotten shots.
-
Across China, life has largely returned to normal — except in the western region of Xinjiang. Some 22 million people have been under heavy lockdown since July — and they're questioning its severity.
-
Parts of Asia that seemed to have COVID-19 under control have witnessed fresh outbreaks. China, Japan and Vietnam, which had few or no cases in the past month or so, are seeing a resurgence.
-
The idea is to reduce the risk of spread of viruses through animal-human contact. Bamboo rat breeders are devastated by the loss of income. And critics say the ban has too many loopholes.
-
Meet some of the people in China who lived through the start of the coronavirus pandemic. They have not forgotten the weeks of isolation, fear and heartbreak.
-
A cluster of COVID-19 cases, linked to a produce market in Beijing, sparked fears of a second wave. Officials are resurrecting some lockdown measures and testing tens of thousands of nearby residents.
-
Officials have discovered 79 symptomatic cases of the coronavirus linked to the Xinfadi food market, prompting a return to partial lockdown measures and fears of a second wave of infections.
-
Before COVID-19 engulfed the Chinese city of Wuhan, Fang Fang was already an award-winning novelist. But her chronicle of the lockdown of her hometown might be her most lasting work.
